Symbyax Journal Ad Features Drawing Of Patient Heading "Into The Light"
This article was originally published in The Pink Sheet Daily
Executive Summary
The reminder ad shows a patient being led by a doctor out of a dense and dark forest into a bright clearing. The spot is part of the product's physician-directed campaign and is not in response to a slower-than-expected launch of the bipolar depression agent, Lilly says.
You may also be interested in...
Arcoxia "Coming Soon" Journal Ads Running As User Fee Date Approaches
The ad first appeared in medical journals in early September, well ahead of the Oct. 30 PDUFA date for the COX-2 inhibitor. Merck says the ad does not reflect expectations of a particular FDA review decision but rather is standard industry practice.
Arcoxia "Coming Soon" Journal Ads Running As User Fee Date Approaches
The ad first appeared in medical journals in early September, well ahead of the Oct. 30 PDUFA date for the COX-2 inhibitor. Merck says the ad does not reflect expectations of a particular FDA review decision but rather is standard industry practice.
Zyprexa Marketing Goes "Back to Basics"
Lilly strategy will focus on identifying patients, promoting new indications/formulations and preserving access. Company acknowledges that combating negative safety impression for the antipsychotic is "not an easy task."